Article Information
History
- March 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Antonio Leidi, MD1,*,#,
- Flora Koegler, MD1,*,
- Roxane Dumont2,
- Richard Dubos2,
- María-Eugenia Zaballa, PhD2,
- Giovanni Piumatti, PhD2,6,
- Matteo Coen, PhD1,
- Amandine Berner, MD1,
- Pauline Darbellay Farhoumand, MD1,
- Pauline Vetter, MD4,
- Prof Nicolas Vuilleumier, MD3,
- Prof Laurent Kaiser, MD4,
- Prof Delphine Courvoisier, PhD5,
- Andrew S Azman, PhD2,
- Prof Idris Guessous, MD2,*,
- Prof Silvia Stringhini, PhD2,*,
- SEROCoV-POP study group
- 1Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland
- 2Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
- 3Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
- 4Geneva Center for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland
- 5General Directorate of Health, Geneva, Switzerland
- 6Institute of Public Health, Faculty of BioMedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
- ↵#Corresponding author: Antonio Leidi, General Internal Medicine, Department of Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland, tel: +41795534559, fax: +41223729202, Antonio.Leidi{at}hcuge.ch
↵* These authors contributed equally to the study
Posted March 20, 2021.
Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study
